amygdalin has been researched along with Cirrhoses, Experimental Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, J; Sun, K; Tang, D; Wang, R; Wu, Y; Yin, S; Zhang, D; Zhu, W | 1 |
1 other study(ies) available for amygdalin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl
Topics: Amygdalin; Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Cell Line; Cell Proliferation; Chemical and Drug Induced Liver Injury; Cytokines; Gene Expression Regulation; Humans; Inflammation Mediators; Kupffer Cells; Liver; Liver Cirrhosis, Experimental; Rats, Sprague-Dawley; Signal Transduction; Transforming Growth Factor beta1 | 2021 |